Xiaobin Gu
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research top 5%
- Immunology top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (11 papers)Inflammatory Biomarkers in Disease Prognosis (9 papers)Cancer-related molecular mechanisms research (5 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Xiaobin Gu
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Oncology 749
- Pulmonary and Respiratory Medicine 364
- Molecular Biology 343
- Cancer Research 343
- Immunology 233
Countries citing papers authored by Xiaobin Gu
This map shows the geographic impact of Xiaobin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Gu more than expected).
Fields of papers citing papers by Xiaobin Gu
This network shows the impact of papers produced by Xiaobin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Gu. The network helps show where Xiaobin Gu may publish in the future.
Co-authorship network of co-authors of Xiaobin Gu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Gu. A scholar is included among the top collaborators of Xiaobin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Gu. Xiaobin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 6 | |
| 8 | 64 | |
| 9 | 3 | |
| 10 | 27 | |
| 11 | 22 | |
| 12 | 48 | |
| 13 | 13 | |
| 14 | 18 | |
| 15 | 6 | |
| 16 | 28 | |
| 17 | 172 | |
| 18 | 11 | |
| 19 | 23 | |
| 20 | 31 |
About Xiaobin Gu
Xiaobin Gu is a scholar working on Cancer Research, Oncology and Endocrinology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Oncology (749 citations), Cancer Research (343 citations) and Pulmonary and Respiratory Medicine (364 citations). Xiaobin Gu has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Xianshu Gao, Tian Tian, Xiaojun Zhang, Yonggang Shi, Shaoqian Sun, Mingwei Ma, Meilian Dong, Hao Yu, Xin Qi and Wen Wang. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.